X

Good News, Bad News about Novel Treatment Resistant Depression Medication

By: Daniel Levin, PharmD candidate c/o 2022               Depression is a terrible beast of an illness to battle with, and…

eMAR

Combating Chronic Diseases with a Plant-Based Diet

By: Ashely Dao, PharmD Candidate c/o 2024               In early 2021, about 6 in 10 American adults had a chronic…

eMAR

Understanding the MELD and PELD Score and Its Role In Liver Transplant Allocation

By: Jason Ifeanyi, PharmD Candidate c/o 2022               The liver is one of the most commonly transplanted solid organs in…

eMAR

Pharmacy Meets Technology: Pharmacy Informatics

By: Tiffany Dominic, PharmD Candidate c/o 2022               As student pharmacists, there is no doubt that we have been hearing…

eMAR

Opioid Addiction During a Public Health Crisis

By: Anjali Rana, PharmD Candidate c/o 2025 and Katharine Russo, PharmD               The Coronavirus disease 2019 (COVID-19) pandemic continues to…

eMAR

Ranitidine (Zantac®) Making a Comeback

By: Mandy Zheng, PharmD Candidate c/o 2024               “Where can I find Zantac?”. From April 2020 to May 2021, the…

eMAR

Dravet’s Syndrome and a Novel Antiepileptic Drug: Cannabidiol (Epidiolex®)

By: Jason Ifeanyi, PharmD Candidate c/o 2022               Epilepsy is a highly prevalent neurological disorder caused by unusual nerve cell…

eMAR

Potentially Life-Threatening Interactions Between Newer Smartphones and ICDs

By: Richa Tamakuwala, PharmD Candidate c/o 2022               There has been a dramatic rise in the number of patients with…

eMAR

A New Approach with an Old Drug: Colchicine and Heart Disease

By: Mathew Fontanez, PharmD Candidate c/o 2022               What place does the familiar gout medication colchicine have in the fight…

eMAR

CAR T-cell therapy for Multiple Myeloma

By: Lyana Sayilar, PharmD Candidate c/o 2022               Multiple myeloma is characterized by an accumulation of abnormal plasma cells in…

eMAR